Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
06/01/2011 | CN102078406A Traditional Chinese medicine for treating insomnia |
06/01/2011 | CN102078397A Traditional Chinese medicine compound and preparation method thereof |
06/01/2011 | CN102078383A Compound ginkgo leaf capsule and tablet preparation method |
06/01/2011 | CN102078381A Medicament to prevent and treat neurasthenia and preparation method thereof |
06/01/2011 | CN102078369A Application of Chinese patent drug for treating peptic ulcer in preparing alcohol resistance medicament |
06/01/2011 | CN102078358A Application of chrysanthemum water extract in improving learning and memory |
06/01/2011 | CN102078331A ICCB-containing compound preparation and preparation method thereof |
06/01/2011 | CN102078330A Compound preparation containing in vitro cultivated calculus bovis (ICCB) and caffeine and preparation method thereof |
06/01/2011 | CN102078327A Application of hydrogen sulfide donor to preparation of medicine for treating central nervous system disease |
06/01/2011 | CN102078322A Medical purpose of piperacillin sodium/tazobactam sodium for injection |
06/01/2011 | CN102078321A Blonanserin-containing medicinal composition and preparation method thereof |
06/01/2011 | CN102078320A Iloperidone pharmaceutical composition and preparation method thereof |
06/01/2011 | CN102078310A Generally linear effervescent oral fentanyl dosage form and methods of administering |
06/01/2011 | CN102078309A Dispersible tablet containing antipsychotic medicines and application thereof |
06/01/2011 | CN102078299A Citicoline sodium liposome solid preparation |
06/01/2011 | CN102078288A Pediatric anesthesia induction oral administration formulation and preparation method thereof |
06/01/2011 | CN102078028A Cigarette for benefiting gallbladder, reducing blood pressure and giving up smoking and preparation method thereof |
06/01/2011 | CN101816751B Medicament for treating epilepsy and tourette syndrome and preparation method thereof |
06/01/2011 | CN101773632B Chinese medicine composition for treating dizziness and preparation method thereof |
06/01/2011 | CN101745066B Medicine for treating senile dementia and preparation method thereof |
06/01/2011 | CN101732458B Compound essential oil having functions of refreshing spirit, restoring consciousness and resisting fatigue, and wet tissue containing same |
06/01/2011 | CN101559175B Compound decoction of divaricate saposhnikovia root and eucommia bark for treating headache |
06/01/2011 | CN101544600B Method for separating and preparing ricinine |
06/01/2011 | CN101537011B Pharmaceutical composition for preventing or treating parkinsonism and preparation method thereof |
06/01/2011 | CN101530040B Essential plant fragrance smell area capable of improving depression symptoms and construction method thereof |
06/01/2011 | CN101500998B Mono-and divalent salts of N-(5-hydroxynicotinoil)-L-glutaminic acid exhibiting psychotropic (antidepressant and anxyolytic), neuroprotective, heroprotective and cerebroprotective action |
06/01/2011 | CN101433645B Chinese medicine preparation for resisting depression and stress-induced mental disorder, and preparation method thereof |
06/01/2011 | CN101428080B Health care essential oil of magnolia flower |
06/01/2011 | CN101323641B Anti-opioid peptide, antagonistic peptide thereof and use thereof |
06/01/2011 | CN101248053B N-oxides as prodrugs of piperazine and piperidine derivatives |
06/01/2011 | CN101229247B Medicine preparation for treating insomnia and preparing method thereof |
06/01/2011 | CN101227917B Medicament with drug rehabilitation function and preparing method thereof |
06/01/2011 | CN101189221B Ampa receptor potentiators |
06/01/2011 | CN101129341B Intra-oral disintegration compositions and process for producing same |
06/01/2011 | CN101076520B Imidazoline derivatives having cb1-antagonistic activity |
05/31/2011 | USRE42412 Materials and methods for the treatment of gastroesophageal reflux disease |
05/31/2011 | US7951948 Spirocyclic cyclohexane compounds |
05/31/2011 | US7951931 Nucleic acid encoding sodium channel SCN3A alpha subunits |
05/31/2011 | US7951909 A polypeptide containing an N-terminal fragment of Amyloid beta (A beta ) peptide linked to a helper T cell epitope (Th) having multiple class II binding motifs; generated antibodies are highly cross-reactive to the soluble A beta 1-42 peptide and the amyloid plaques in the brain |
05/31/2011 | US7951821 N-[phenyl(piperidin-2-yl)methyl]benzamide derivatives, preparation thereof, and use thereof in therapy |
05/31/2011 | US7951820 Triazole compounds useful as protein kinase inhibitors |
05/31/2011 | US7951811 Pyrrolo[2,3-D]pyrimidine derivatives substituted with a cyclic amino group |
05/31/2011 | US7951810 Substituted pyrrolo[2,3-d]pyrimidines as inhibitors of E1 activating enzymes |
05/31/2011 | US7951798 Polymorphs of olanzapine hydrochloride |
05/31/2011 | US7951797 Substituted diazepan orexin receptor antagonists |
05/31/2011 | US7951795 Constrained spirocyclic compounds as CGRP receptor antagonists |
05/31/2011 | US7951371 Soluble lymphotoxin-β receptor fusion protein and methods for inhibiting lymphotoxin β-receptor signaling |
05/31/2011 | CA2601716C Methods and compositions for the treatment of attention deficit hyperactivity disorder and hyperphenylalanemia |
05/31/2011 | CA2517493C Therapeutic patch with polysiloxane matrix comprising capsaicin |
05/31/2011 | CA2497450C Pyrazolopyrimidines as cyclin dependent kinase inhibitors |
05/31/2011 | CA2475764C New inhibitors of histone deacetylase |
05/31/2011 | CA2465750C 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]-indole-1-carboxamide derivatives, their preparation and therapeutic use |
05/31/2011 | CA2455635C Use of thiazole derivatives for preparing a medicine for protecting mitochondria |
05/31/2011 | CA2438661C Yeast screens for agents affecting protein folding |
05/31/2011 | CA2398929C Neuroprotective, antithrombotic and anti-flammatory uses of activated protein c (apc) |
05/31/2011 | CA2369725C Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines |
05/26/2011 | WO2011063415A2 Methods for treating mild cognitive impairment |
05/26/2011 | WO2011063272A1 Amino heteroaryl compounds as beta-secretase modulators and methods of use |
05/26/2011 | WO2011063233A1 Amino heteroaryl compounds as beta-secretase modulators and methods of use |
05/26/2011 | WO2011063178A2 Intravenous infusion of curcumin and a calcium channel blocker |
05/26/2011 | WO2011063164A2 Sustained release cannabinoid medicaments |
05/26/2011 | WO2011063115A1 Combination of nootropic agent with one or more neurogenic or neurogenic sensitizing agents for stimulating or increasing neurogenesis |
05/26/2011 | WO2011062864A2 Inhibitors of nox enzymes and methods of use thereof |
05/26/2011 | WO2011062777A1 Methods and compositions for the treatment of psychotic disorders through the identification of the sult4a1-1 haplotype |
05/26/2011 | WO2011062550A1 Benzoimidazole compounds and uses thereof |
05/26/2011 | WO2011062284A1 A cycloalkane derivative |
05/26/2011 | WO2011062253A1 Novel fused pyrimidine derivative |
05/26/2011 | WO2011062194A1 Aminopyridine derivative |
05/26/2011 | WO2011061754A1 A novel 3-substituted 7-imino-2-thioxo-3, 7-dihydro-2h-thiazolo [4,5-di pyrimidin-6-yl - and process for preparation thereof |
05/26/2011 | WO2011061751A1 BICYCLIC COMPOUNDS AS α4β2 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS |
05/26/2011 | WO2011061744A2 Novel arylated camphenes, processes for their preparation and uses thereof |
05/26/2011 | WO2011061469A1 Indazole derivatives and their use for blockading voltage dependent sodium channels |
05/26/2011 | WO2011061332A1 Pharmaceutical composition comprising propofol |
05/26/2011 | WO2011039388A3 3-indazolyl ether family with cannabinoid and/or cholinergic properties |
05/26/2011 | WO2011039308A3 Gluten-free foodstuff |
05/26/2011 | WO2011011692A3 Methods of treating and preventing/reducing the likelihood of mesial temporal lobe epilepsy (tle) |
05/26/2011 | WO2011011330A3 Inhibitors of d-amino acid oxidase |
05/26/2011 | WO2011006097A3 Methods For Treating Toxicity |
05/26/2011 | WO2011005052A3 Novel arylpiperazine-containing imidazole 4-carboxamide derivatives and pharmaceutical composition comprising same |
05/26/2011 | WO2011003064A9 Methods of treating neuropathic pain |
05/26/2011 | WO2010151755A3 TREATMENT OF INFLAMMATORY DISEASES USING miR-124 |
05/26/2011 | WO2010144711A3 Immunological targeting of pathological tau proteins |
05/26/2011 | US20110124739 Use of Sphingosine-1-phosphate (S1P) Receptor Agonists for the Treatment of Brain Degenerative Diseases |
05/26/2011 | US20110124735 Carbonylamino derivatives useful for the treatment of certain inflammatory disorders |
05/26/2011 | US20110124731 Treatment Of Neurodegenerative Diseases And Cancer Of The Brain Using Histone Deacetylase Inhibitors |
05/26/2011 | US20110124721 Methods of treating traumatic brain injury by administering baicalein preparation |
05/26/2011 | US20110124712 Anti-cancer composition comprising microrna molecules |
05/26/2011 | US20110124706 SOCS3 Inhibition Promotes CNS Neuron Regeneration |
05/26/2011 | US20110124705 Prodrugs of alpha-2-delta ligands, pharmaceutical compositions and uses thereof |
05/26/2011 | US20110124699 Method for treating nervous system disorders and conditions |
05/26/2011 | US20110124690 Compositions and methods for treating cancer or a neurotrophic disorder |
05/26/2011 | US20110124678 Treatment with alpha 7-selective ligands |
05/26/2011 | US20110124676 Biaryl substituted azabicyclic alkane derivatives |
05/26/2011 | US20110124673 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
05/26/2011 | US20110124672 Thienyl Compounds |
05/26/2011 | US20110124671 Spiroindenes and spiroindanes as modulators of chemokine receptors |
05/26/2011 | US20110124668 Novel indole derivative having, carbamoyl group, ureido group and substituted oxy group |
05/26/2011 | US20110124666 3,4-dihydropyrimidine trpa1 antagonists |
05/26/2011 | US20110124663 Substituted dioxopiperidines and dioxopyrrolidines as mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction |
05/26/2011 | US20110124662 Substituted Carbamate Derivatives as Modulators of Corticotropin-Releasing Factor Receptor Activity |